PI3Ks control signal transduction triggered by growth factors and G-protein-coupled receptors and regulate an array of biological processes, including cellular proliferation, differentiation, survival and migration. Herein, we investigated the role of PI3Kc in the pathogenesis of EAE. We show that, in the absence of PI3Kc expression, clinical signs of EAE were delayed and mitigated. PI3Kc-deficient myelin oligodendrocyte glycoprotein (MOG) 35-55 -specific CD4 1 T cells appeared later in the secondary lymphoid organs and in the CNS than their WT counterparts. Transfer of WT CD4 1 cells into PI3Kc À/À mice prior to MOG 35-55 immunisation restored EAE severity to WT levels, supporting the relevance of PI3Kc expression in Th cells for the pathogenesis of EAE; however, PI3Kc was dispensable for Th1 and Th17 differentiation, thus excluding an altered expression of these pathogenetically relevant cytokines as the cause for ameliorated EAE in PI3Kc À/À mice. These findings demonstrate that PI3Kc contributes to the development of autoimmune CNS inflammation.
Introduction
EAE is an autoimmune disorder of the CNS that serves as an animal model for the human disease multiple sclerosis (MS) [1] . Both in MS and EAE, Th1 and Th17 myelin-reactive CD4 1 T lymphocytes gain access to the CNS and, in concert with other infiltrating mononuclear cells such as macrophages, cause inflammation, oligodendrocyte cell death, demyelination, axonal degeneration and progressive ascending paralysis [2] [3] [4] .
PI3Kg belongs to the Class IB family of dual-specificity lipid and protein kinases that catalyse the phosphorylation of phosphatidylinositol-4,5-biphosphate into the second messenger phosphatidylinositol-3,4,5-triphosphate [5, 6] . First characterised in the early 1990s, PI3Kg is mainly expressed in blood and These are not the final page numbers Correspondence: Dr. Thomas Kamradt e-mail: Immunologie@mti.uni-jena.de endothelial cells [7] and is activated in response to most G-protein-coupled chemokine receptors [8, 9] . Thus, PI3Kg regulates migration of different cell populations such as neutrophils, macrophages, DCs and T cells [10] [11] [12] [13] [14] . Recently, a role for PI3Kg in regulating the in vivo migration of Ag-experienced effector CD4
1 T cells into inflammatory sites has been described previously [15] . Moreover, migration of Th17 cells in response to CCR2 and CCR6 agonists has been found to be PI3K dependent [16] . In addition, PI3Kg has been involved in other inflammatory cellular processes such as superoxide production by neutrophils [17] , NK cell cytotoxicity [18] and T-cell activation [19] . Recent studies have proposed PI3Kg as a target for the treatment of inflammatory pathologies including asthma [20, 21] , rheumatoid arthritis [22, 23] , allergy [24] [25] [26] , systemic lupus erythematosus [27] and pancreatitis [28, 29] . Yet, the function of PI3Kg in EAE pathogenesis remains unclear. Here, we investigated the effect of PI3Kg deletion on the course of chronic EAE and its influence on the immune mechanisms underlying pathogenesis.
Results
Late onset and reduced severity of EAE in PI3Kc À=À mice Following s.c. immunisation with myelin oligodendrocyte glycoprotein (MOG) peptide in CFA and administration of pertussis toxin i.v., WT mice reproducibly developed a severe, chronic encephalomyelitis with clinical signs of disease appearing between days 13 and 19 post-immunisation (pi) (Fig. 1A) . The onset of clinical symptoms in PI3Kg À/À mice was delayed by approximately 10 days compared with the WT mice ( Fig. 1A and Table 1 ). Disease severity, as judged by the maximal and cumulative clinical scores, was significantly lower in PI3Kg
À/À mice ( Table 1) . Reduced severity was also revealed by the reduced body weight loss that PI3Kg À/À mice experienced during the symptomatic phase of EAE when compared with WT mice (Fig. 1B) . Moreover, although more than 90% of the WT mice reached scores Z3, less than 50% of the PI3Kg À/À mice developed a complete hind leg paralysis (score 5 3) (Fig. 1C) , which mostly improved within 24 h. In addition, although approximately 30% of the WT mice died, survival in PI3Kg
mice was 100% in all experiments performed (Table 1 ). Thus, both EAE incidence and mortality were lower in PI3Kg À/À than in WT mice, suggesting that PI3Kg might be important for EAE onset as well as for its clinical outcome. To characterise disease progression at the level of tissue damage, CNS inflammatory lesions during the symptomatic phase of EAE (day 16 pi) were examined in WT and PI3Kg À/À mice. WT mice with acute symptoms of EAE (score Z3) presented abundant cell infiltrates dominated by macrophages and T cells including some neutrophils (Fig. 1D, i-iv) . Demyelinating lesions, as assessed by Luxol fast blue (LFB) staining, were present in the spinal cord and absent in the brain (Fig. 1D-i , and data not shown). On the contrary, at day 16, PI3Kg À/À mice showed minimal or absent spinal cord inflammatory infiltrates (Fig. 1D , v-viii).
Delayed immune response in the peripheral lymphoid organs of PI3Kc À=À mice
To gain mechanistic insights into the effects of PI3Kg deficiency during EAE, draining lymph nodes (dLN) and spleens from mice were removed before immunisation and on days 9 and 15 after MOG immunisation. Absolute cell numbers were determined and in vitro recall assays were performed to examine cytokine production and Ag-specific proliferation. Before immunisation, total cell counts were similar in the secondary lymphatic organs from PI3Kg À/À mice and WT controls ( Fig. 2A) . On the contrary, during the induction phase of EAE (day 9) when neither WT nor PI3Kg À/À mice displayed clinical signs of disease, total cell numbers were significantly lower in PI3Kg À/À spleen and dLN compared with WT controls ( Fig. 2A) . At day 15 pi, when WT but not PI3Kg À/À mice already displayed severe signs of EAE (score Z3), total cell numbers in the dLN of WT mice were slightly decreased compared with day 9 pi. Cellularity in the spleen of WT mice at this time point was approximately half of the total cell numbers compared with day 9 pi (Fig. 2A, black bars) . On the contrary, total cell numbers in dLN and spleens of PI3Kg À/À mice were slightly increased compared with day 9 pi (Fig. 2A , grey bars). At day 15 pi, total cell numbers in spleens of PI3Kg À/À mice were significantly higher than in their WT counterparts ( Fig. 2A) . Proliferation was evaluated in total dLN cells and splenocytes after in vitro re-stimulation for 72 h. At day 9 pi, splenocytes and dLN cells from PI3Kg À/À mice showed significantly lower proliferation than WT controls when re-stimulated in the presence of MOG peptide (Fig. 2B ). Proliferation in response to the cognate Ag at day 15 pi reached a similar magnitude in both PI3Kg Sixteen days after immunisation, the percentage of MOGspecific Th cells that produced IL-17A or IFN-g in the dLN had already decreased in the WT mice ( In PI3Kg À/À spleens, the number of MOG-specific cells at day 3 pi was only half of the number found at the same time point in WT mice (Fig. 3B , left lower panel). In these mice, the number of MOG-specific T cells rose first between day 10 and day 13 pi and reached a peak at day 17 pi, but the absolute numbers were still lower than in WT spleens at day 13 pi. Thus, by day 10 pi the number of MOG-specific Th cells in the secondary lymphatic organs is much higher in WT than in PI3Kg À/À mice (Fig. 3B ). Moreover, within this larger pool of MOG-specific Th cells in WT mice, the relative frequency of cytokine producers is at least ten-fold higher than in their PI3Kg À/À counterparts ( Fig. 3A) , resulting in 4100-fold higher numbers of cytokine-producing MOG-specific Th cells 10 days after immunisation in WT mice. Seventeen days after immunisation, both the numbers of MOG-specific Th cells (Fig. 3B ) and the frequency of cytokine producers among them are similar in PI3Kg À/À and WT mice. Taken together, these data imply a retarded priming of Ag-specific Th cells in the PI3Kg À/À mice upon immunisation with MOG peptide.
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T cells (Fig. 4B , iv, ix) and neutrophilic granulocytes (Fig. 4B, v,  x) were observed. These are not the final page numbers 5C and Supporting Information Fig. S3B, left panel) . Three wk after immunisation, when PI3Kg À/À mice had developed a more severe EAE, the majority of the MOG-specific Th cells isolated from the CNS were endogenous Ly5.1 À PI3Kg-deficient Th cells (Fig. 5B, lower panel, Fig. 5C and Supporting Information Fig. S3B, right panel) . Thus, the data indicate that during EAE, MOG-specific WT Ly5.1 1
Th cells reach the CNS of PI3Kg
À/À mice earlier (d15) than the endogenous (Ly5.1 À ) MOG-specific PI3Kg-deficient Th cells.
PI3Kc is dispensable for the differentiation of naïve T cells into Th1 and Th17 cells
Since cell infiltration into the CNS, although later, was comparable in PI3Kg À/À and WT mice with severe symptoms of EAE, we hypothesised that the less severe form observed in these mice might be a result of other effector mechanisms affected by PI3Kg deficiency. Several studies indicate that both Th1-and Th17 CD4
1 -mediated cell responses are critical in the pathogenesis of EAE [36, 37] 
. DCs instruct Th-cell differentiation in vivo and
These are not the final page numbers Fig. S3A and B) . Data show mean7SEM (n 5 3 mice/group). Data shown are from one of the two independent experiments. in vitro. Therefore, the influence of PI3Kg deficiency in BMDC and naïve T cells to drive Th cell differentiation was next investigated. Naïve CD4 
Treatment of EAE by blockade of PI3Kc activity
Given the lower severity of EAE found in PI3Kg À/À mice, we next determined whether pharmacological inhibition of the PI3Kg catalytic activity in WT animals would also affect EAE development. WT mice received PI3Kg inhibitor i.p. starting after the onset of clinical symptoms on day 13 pi with MOG peptide.
Milder signs of the disease and reduced body weight loss ( Fig. 7A and B) were observed in mice treated with PI3Kg inhibitor compared with mice treated with vehicle although to a lesser extent than in PI3Kg À/À mice.
Discussion
In the present study, we investigated the effect of PI3Kg deficiency on the pathogenesis of EAE. We show that in PI3Kg À/À mice, clinical signs of EAE developed slower and were less severe than in WT controls. During the first 10 days after immunization, the number of MOG-specific Th cells was drastically lower in the secondary lymphatic organs of PI3Kg À/À mice than in WT mice. In addition, within this smaller pool of MOG-specific Th cells, the percentage of cytokine producers was much lower in PI3Kg À/À mice than in WT. At day 16 pi, both the numbers of MOG-specific Th cells and the percentage of cytokine producers within the MOG-specific Th cell pool were similar in the secondary lymphatic organs of PI3Kg
À/À mice and in WT mice. Upon Ag exposure, migration of Ag carrying DCs to the secondary lymphoid organs is a prerequisite for the activation of naïve T cells. Thus, DC migration represents a critical step to trigger an optimal immune response. Previous studies have demonstrated that PI3Kg plays a non-redundant role in DC trafficking and T-cell activation [10] . DCs from PI3Kg À/À mice have a reduced ability to respond to chemokines in vitro and ex vivo and to travel to dLN under inflammatory conditions [10] . Importantly, this reduced ability of Ag-loaded DCs to migrate from the periphery to dLN results in impaired delayed-type hypersensitivity reactions in PI3Kg À/À mice [10] . Pertinent to our study, Del Prete et al. also found that although DCs from PI3Kg À/À mice had an impaired capacity to travel to the dLN, they localised to the T-cell paracortical areas just as WT DCs once
These are not the final page numbers Fig. S1A ). Bar graph summarizing data from three independent experiments is shown in Supporting Information Fig. S4. they had reached the LN [10] . These findings complement our analyses of Th-cell responses following MOG immunisation. Collectively, our findings and those reported by Del Prete and colleagues strongly suggest that the lack of PI3Kg delays T-cell priming in the secondary lymphoid organs, thus prolonging the induction phase, and consequently, the clinical onset of disease. Moreover, PI3Kg
À/À T cells have been reported to exhibit dramatic defects in their ability to traffic to peripheral inflammatory sites in vivo [15] . This functional deficiency is likely to contribute to the delayed onset of EAE in the PI3Kg À/À mice.
In addition to the late onset of EAE, we have demonstrated that disease severity was also reduced in PI3Kg À/À mice compared with their WT counterparts. Our transfer experiments showed that although WT CD4 1 T cells alone were not sufficient to accelerate EAE onset in PI3Kg À/À mice, disease severity in PI3Kg À/À mice that received WT CD4 1 T cells was comparable to WT mice. Once activated in the secondary lymphoid organs, migration of autoreactive CD4 1 T cells into the CNS represents a critical pathogenic event in the initiation of CNS inflammation [4, 38] . Analysis of cellular infiltrates in the CNS revealed that MOG -specific CD4 1 T cells appeared later in the CNS of PI3Kg À/À mice and their absolute numbers remained lower than in WT mice even at the peak of disease. These findings are fully compatible with combined effects of a deficient migratory capacity of PI3Kg À/À DCs, which results in delayed T-cell priming [10] , and a reduced migratory capacity of PI3Kg À/À T cells [15] .
This concept is further supported by our finding that adoptively transferred PI3Kg effector T cells in DTH reaction [15] . Additionally, the lower CD4 1 memory survival observed in PI3Kg À/À mice [39] may contribute to the less severe symptoms observed during the chronic phase. Our findings may be confounded by the effects of PI3Kg deficiency in other pathogenetically relevant cell types. PI3Kg has been extensively involved in leukocyte migration; however, its role in regulating cell migration seems to be different according to the cell type and the chemokine receptor involved. In the absence of PI3Kg function, the in vitro chemotactic response of neutrophils toward different chemoattractants (IL-8, fMLP and C5a) was severely impaired [11, 14] . In vivo, however, PI3Kg-independent neutrophil emigration in response to chemokines such as CXCL1 or CXCL2 has also been observed [40, 41] .
PI3Kg deficiency does not affect the expression of TCRab, CD3, CD4, CD8, CD28, CD45, CD44, LFA-1, CD25 and CD69 by CD4 or CD8 T cells [14] . In agreement, our in vitro studies showed that PI3Kg À/À CD4 1 T cells were able to differentiate into Th0, Th1 or Th17 cells to a similar extent than their WT counterparts. The absence of PI3Kg expression in BMDC did not affect their capacity to induce Th-cell subset differentiation in vitro. In summary, these results suggest that the delayed T-cell priming and expansion of Ag-specific CD4 1 T cells observed in PI3Kg
mice during EAE is not due to an intrinsic defect in T-cell activation, or cytokine production. Finally, we showed that pharmacological inhibition of PI3Kg after EAE onset could also influence disease severity. Further studies are required to determine if PI3Kg could be a therapeutic target for MS.
In summary, here we showed that PI3Kg contributes to disease severity as well as the time of onset of EAE by acting at different levels. On one hand, the impaired ability of PI3Kg À/À DCs to migrate delays T-cell priming in the peripheral lymphoid organs. On the other hand, migration defects in PI3Kg À/À encephalitogenic CD4 1 T cells might contribute to the delayed onset and lower severity of disease observed in PI3Kg-deficient mice.
Materials and methods Mice
PI3Kg-deficient (PI3Kg À/À ) mice were described earlier [11] and backcrossed to the C57BL/6 background for more than ten generations. WT and PI3Kg À/À littermates were maintained at the Animal Research Facility, Friedrich Schiller University Jena, Germany and kept under SPF conditions. All animal experiments were approved by the appropriate institutional and governmental committees for animal welfare (02-11-05).
These are not the final page numbers Induction and assessment of EAE EAE was induced in 8-to 12-wk-old mice by s.c. immunisation with 200 mg MOG peptide, aa35-55 (Peptides&Elephants, Nuthetal, Germany) emulsified in CFA, followed by i.v. injection of 200 ng pertussis toxin (Sigma-Aldrich) on days 0 and 2. To quantify disease severity, scores were assigned daily on a scale of 0-5 as follows: 0, no paralysis; 0.5, clumsy gait; 1, limp tail; 2, limp tail and partial hind leg paralysis; 3, complete hind leg paralysis; 4, tetraparesis and 5, moribund. Animals were euthanised if scores reached grade 4. Treatment with PI3Kg inhibitor was done as follows: C57BL/6 mice were treated with 30 mg/kg 5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione [27] (Calbiochem) i.p., every 12 h for 4 days starting after the onset of clinical symptoms on day 13 pi. In these experiments, scores of 5 were included in the calculation of the mean score for the remainder observation period.
Immunohistochemistry
Sections were stained with H&E or with LFB and periodic acid-Schiff (PAS) reagent for the analysis of inflammation and demyelination. In adjacent serial sections, immunohistochemistry was done with antibodies recognizing macrophages (anti-Mac-3; M3/84; 0781D; BD Pharmingen) or T cells (anti-CD3; CD3-12; MCA 1477; Serotec) as described previously [42] . Bound Ab was visualised by an avidin-biotin technique with diaminobenzidine as the chromogen. Neutrophils were detected by chloracetic esterase histochemistry. Nuclei were counterstained with hematoxylin.
Proliferation and cytokine assays
To determine proliferation, LN or spleen single-cell suspensions were plated in a 96-well round-bottom plate (Greiner Bio-One, Solingen, Germany) at a density of 1 Â 10 6 cells/mL in RPMI1640 culture medium supplemented with 10% FCS, 100 U/mL penicillin, 100 mg/mL streptomycin and 50 mM 2-mercaptoethanol. Cells were stimulated with 10 mg/mL MOG , in triplicate for 72 h. For the last 18 h, 1 mCi/well 3 [H]-thymidine (GE Healthcare, München, Germany) was added. 3 [H]-thymidine incorporation
was measured with a b-scintillation counter. To determine cytokines, supernatants were harvested after 48 h of incubation and analysed for the levels of secreted cytokines using standard sandwich ELISA procedures (IFN-g was from eBiosciences; IL-17A from R&D Systems).
FACS and mAbs
Unless otherwise indicated, mAbs were grown and purified and/ or conjugated from hybridoma supernatants in our laboratory. Single-cell suspensions from dLN (inguinal, para-aortic, 1 Â 10 7 cells/mL) were cultured in 48-well plates in the presence of 30 mg/mL MOG 35-55 for 5 h. Brefeldin A (Sigma-Aldrich) was added to a final concentration of 5 mg/mL for the last 3 h. Cells were stained with a viability dye (Aqua fixable live/dead staining kit; Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. After fixation with 2% paraformaldehyde for 20 min, cells were permeabilised with 0.5% saponin (SigmaAldrich) and incubated with anti-CD16/32 (2.4G2/75; 100 mg/ mL) and rat IgG (200 mg/mL; Dianova, Hamburg, Germany) to prevent unspecific binding. Cells were stained with anti-CD4 (RM4-5)-APC-A750, IFN-g (XMG1.
2)-PECy7, IL-17A (eBio17B7)-A488, IL-2 (JES6-5H4)-APC and anti-TNF-a (MP6-XT22)-PacBlue all from eBiosciences and anti-CD154 (MR1)-PE purchased from Miltenyi Biotec (Bergisch-Gladbach, Germany); 1 000 000 events were acquired for each sample using a LSRII cell cytometer (BD Biosciences). To determine CNS infiltrates, cell suspensions from the brains and spinal cords were prepared as described previously [36] . Cells were re-stimulated in vitro and analysed by FACS for Ly5.1 (eBiosciences), CD4 and CD154 expression. Gates for CD154 were set using unstimulated control samples as described previously [33] . Alternatively, cells were directly stained with anti-B220(RA3-6B2)-PacBlue, CD4(GK1. 
CD4
1 Th-cell purification and in vitro stimulation
To prepare BM-derived DCs, BM cells were obtained from the femur and tibia of PI3Kg À/À and PI3Kg 1/1 littermates and cultured for 7 days with 10% granulocyte-macrophage-colonystimulating factor (GM-CSF) supernatant obtained from the Ag8653 myeloma cell line [43] . Naïve CD4 
Statistical analysis
All data are presented as the mean7SEM unless otherwise indicated. Statistical analysis (non-parametric Mann-Whitney U-test) was performed with SPSS16.0 (SPSS, Chicago, IL, USA) or with GraphPad Prism 5.
